Guidelines for prevention of thromboembolic events in valvular heart disease. Ad Hoc Committee of the Working Group on Valvular Heart Disease, European Society of Cardiology

J Heart Valve Dis. 1993 Jul;2(4):398-410.
No abstract available

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Anticoagulants / pharmacokinetics
  • Bioprosthesis
  • Female
  • Heart Valve Diseases / blood
  • Heart Valve Diseases / mortality
  • Heart Valve Diseases / surgery*
  • Heart Valve Prosthesis*
  • Hemorrhage / blood
  • Hemorrhage / chemically induced
  • Hemorrhage / mortality
  • Hemorrhage / prevention & control
  • Humans
  • Long-Term Care
  • Postoperative Complications / blood
  • Postoperative Complications / mortality
  • Postoperative Complications / prevention & control*
  • Pregnancy
  • Prosthesis Design
  • Risk Factors
  • Survival Rate
  • Thromboembolism / blood
  • Thromboembolism / mortality
  • Thromboembolism / prevention & control*

Substances

  • Anticoagulants